Treatment Trade-offs

Semaglutide is presented as a GLP-1 agonist associated with substantial weight loss and possible benefits beyond weight reduction. Medication access does not imply appropriateness because prescriptions have indications, side effects, legal…

2 sources - 6 claims

Semaglutide is presented as a GLP-1 agonist associated with substantial weight loss and possible benefits beyond weight reduction. Medication access does not imply appropriateness because prescriptions have indications, side effects, legal constraints, and monitoring requirements. Semaglutide can have gastrointestinal side effects including vomiting, severe urgency, and unpleasant belching. Taking medication involves a trade-off where symptom relief comes with the creation of other symptoms. Patients taking medication must understand they are making a trade-off. Modafinil may be useful for severe sleepiness, late-night driving, or jet lag when medically appropriate.